Why Medifast, Inc.’s (MED) Stock Is Up 5.78%
As of Tuesday, October 27, Medifast, Inc.’s MED share price has surged by 5.78%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Jenna Brashear
Jenna Brashear
Cynthia McLaughlin
| Share Statistics | MED | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $126.9 | $243.2 | 25% |
|
| Shares Out (Mil) | 11.2 | 22.7 | 22% |
|
| Institutional Ownership | 94.3% | 62.2% | 64% |
|
| Float (Mil) | 8.4 | 31.5 | 17% |
|
| Beta | 0.69 | 0.70 | 39% |
|
| Avg Daily Volume (000s) | 106 | 138 | 36% |
|
| Price Change (52-week) |
9.9% | 52.2% | 60% |
|
| Growth | MED | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (16.2%) | (0.9%) | 3% |
|
| Net Income (5yr) | (16.9%) | (8.8%) | 23% |
|
| EPS (5yr) | (17.0%) | (1.3%) | 16 |
|
| Dividends (5yr) | (14.9%) | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.1%) | (15.9%) | 51% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | $0.010 | ($0.860) | ($0.040) | |
| Month Ago EPS | ($0.120) | ($1.150) | ($0.280) | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | ($0.120) | ($1.150) | ($0.280) | |
| Year/Year Chg | (100.6%) | (49.4%) | na | |
| Financials | MED | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $300 | $650 | 35% |
|
| Net Income (TTM) (Mil) | ($41) | $3 | 17% |
|
| EPS (TTM) | ($3.687) | $0.200 | 9% |
|
| Operating Cash Flow (TTM) (Mil) | $0 | $20 | 32% |
|
| Net Cash Flow (TTM) (Mil) | ($41) | $3 | 23% |
|
| Long-Term Debt (Q1) (Mil) | $18 | $28 | 32% |
|
| Enterprise Value (Q1) (Mil) | ($22) | $303 | 2% |
|
| Valuation | MED | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.70 | 1.25 | 17% |
|
| P/E | na | 14.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.4 | na |
|
| Ratios | MED | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 69.2% | 63.3% | 80% |
|
| Net Margin | (13.6%) | 3.3% | 19% |
|
| ROA | (16.1%) | 1.9% | 21% |
|
| ROE | (20.7%) | (3.2%) | 23% |
|
| Liabilities to Assets | 24.8% | 47.3% | 17% |
|
| F-Score | 2 | 5 | na |
|
Medifast, Inc. did not pass any screens on 11/18/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors